Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

计划入组 21 人 · 首次发布于 2004 年 8 月 12 日

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

计划入组 66 人 · 首次发布于 2015 年 11 月 4 日

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

计划入组 38 人 · 首次发布于 2013 年 6 月 12 日

AM9-79

topoisomerase I inhibitors (cancer)

topoisomerase I inhibitor (sepsis)

Universitetet i Oslo

Norway

I-SHOU UNIVERSITY

Taiwan

i-SENS, Inc.

South Korea

FDA Clears IND Application for Zymeworks' Novel FRα-Targeted ADC, ZW191

Akari Reports Breakthrough Preclinical Data for AKTX-101 in KRAS-Mutated Pancreatic Cancer, Stock Surges 50%

FDA Grants Orphan Drug Designation to LMP744 for Glioma Treatment